| [1] PubMed ID: | 35778954 |
| Disease Name: | Ovarian Neoplasms |
| Sample: | SOC patients |
| Dysfunction Pattern: | Expression(lower expressed) |
| Validated Method: | Western Blot//ISH//Transfection//Wound Healing Assay//CCK8//qRT-PCR//Colony Formation Assay//Bioinformatics Analysis//Transwell Assay |
| Description: | LIFR-AS1 was lowly expressed in SOC, which was correlated with the poor prognosis of SOC patients. LIFR-AS1 overexpression promoted the expressions of cleaved caspase-3 and E-cadherin while suppressing the malignant behaviors (proliferation, migration, and invasion) of SOC cells, the expressions of PCNA, N-cadherin, and Snail. Besides, silencing LIFR-AS1 exerted the effects opposite to overexpressed LIFR-AS1. |
| Causality: | Yes |
| Causal Description: | LIFR-AS1 overexpression promoted the expressions of cleaved caspase-3 and E-cadherin while suppressing the malignant behaviors (proliferation, migration, and invasion) of SOC cells, the expressions of PCNA, N-cadherin, and Snail. Besides, silencing LIFR-AS1 exerted the effects opposite to overexpressed LIFR-AS1. |
| Clinical-realted Application: | Low expression of LIFR-AS1 in SOC was associated with the tumor size, clinical stage, lymph node metastasis, and distant metastasis. |
|